Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: A meta‐analysis of randomized controlled trials
Objective The aim of this study was to evaluate the efficacy and safety of the dopaminergic‐
enhancing agent modafinil/armodafinil (MoArm) as adjunctive treatment for bipolar …
enhancing agent modafinil/armodafinil (MoArm) as adjunctive treatment for bipolar …
Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: A meta‐analysis of randomized controlled trials.
NA Nunez, B Singh, F Romo‐Nava… - Bipolar …, 2020 - search.ebscohost.com
Objective: The aim of this study was to evaluate the efficacy and safety of the dopaminergic‐
enhancing agent modafinil/armodafinil (MoArm) as adjunctive treatment for bipolar …
enhancing agent modafinil/armodafinil (MoArm) as adjunctive treatment for bipolar …
[PDF][PDF] Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: A meta-analysis of randomized controlled trials
NA Nunez, B Singh, F Romo-Nava, B Joseph, M Veldic… - academia.edu
Objective: The aim of this study was to evaluate the efficacy and safety of the dopaminergic-
enhancing agent modafinil/armodafinil (MoArm) as adjunctive treatment for bipolar …
enhancing agent modafinil/armodafinil (MoArm) as adjunctive treatment for bipolar …
Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: A meta-analysis of randomized controlled trials
NA Nunez, B Singh, F Romo-Nava… - Bipolar …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective The aim of this study was to evaluate the efficacy and safety of the dopaminergic-
enhancing agent modafinil/armodafinil (MoArm) as adjunctive treatment for bipolar …
enhancing agent modafinil/armodafinil (MoArm) as adjunctive treatment for bipolar …
Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: A meta-analysis of randomized controlled trials
NA Nunez, B Singh, F Romo-Nava… - Bipolar …, 2020 - mayoclinic.elsevierpure.com
Objective: The aim of this study was to evaluate the efficacy and safety of the dopaminergic-
enhancing agent modafinil/armodafinil (MoArm) as adjunctive treatment for bipolar …
enhancing agent modafinil/armodafinil (MoArm) as adjunctive treatment for bipolar …
Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: A meta-analysis of randomized controlled trials
NA Nunez, B Singh, F Romo-Nava, B Joseph… - Bipolar …, 2020 - safetylit.org
OBJECTIVE: The aim of this study was to evaluate the efficacy and safety of the
dopaminergic-enhancing agent modafinil/armodafinil (MoArm) as adjunctive treatment for …
dopaminergic-enhancing agent modafinil/armodafinil (MoArm) as adjunctive treatment for …
Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: A meta-analysis of randomized controlled trials.
NA Nunez, B Singh, F Romo-Nava, B Joseph… - Bipolar …, 2020 - europepmc.org
Objective The aim of this study was to evaluate the efficacy and safety of the dopaminergic-
enhancing agent modafinil/armodafinil (MoArm) as adjunctive treatment for bipolar …
enhancing agent modafinil/armodafinil (MoArm) as adjunctive treatment for bipolar …